Navigation Links
BIO 2006 aftermath and a taste of bio-generics

One of my favorite Rolling Stones' albums, not necessarily their best mind you, growing up was "Aftermath", an appropriate label for this period following all the intensity and excitement of BIO 2006- Chicago.

As BIO 2006 - Chicago is still fresh in our minds, I was going to give my take on the outcome, but so many others have already done so that I will wai......

Full article >>> addressed the worldwide generic pharmaceutical market. The reality is that the generic market differs widely around the world due to the role of patents, physician compensation, patient insurance reimbursement, and other factors in each country.

In places like India where patents are just beginning to take effect, prices are among the lowest in the world but will gradually rise. On the ot......

Full article >>> r patents expire (or have already expired some time ago), and a number of companies have lined up to both produce and launch these products in Europe and the United States, but the regulatory authorities in both regions have put the brakes on any approval process.

Traditionally, generics have been able to get FDA approval through a relatively simple Abbreviated New Drug Approval (ANDA) pr......

Full article >>> CompanyActive DrugPatent Expiration DateGlobal Sales(2002)HumulinEli LillyHuman insulin2001$1.0 billionIntron ASchering-PloughAlpha-interferon2002$2.5 billionProcritAmgen/J&Jerythropoietin<......

Full article >>> as been incredible jockeying for worldwide position in the generic market by several major players:

1. Teva Pharmaceuticals - Headquartered outside of Tel Aviz, Israel, ratcheted up its worldwide presence by the acquisition of fellow generic company IVAX last year and Sicor the year before.

2. Sandoz Pharmaceuticals (a division of pharmaceutical mega-player Novartis......

Full article >>> -Hetero Drugs-Hikal--IPCA Labs-Jal Limited--Krebs Biochemicals--Lupin-Malladi Drugs--......

Full article >>> you know that this is heating up, Sandoz filed a lawsuit against the FDA in September, 2005 regarding non-approval of its human growth hormone product.

The issue the FDA is grappling with is a need to show greater safety with these products requiring companies to do more clinical trials for bio-generics. It appears that a physician prescription will also be coupled with dispensing of the......

Full article >>> member of the Illinois Biotechnology Industry Organization. He can be reached at rosenmichaels@aol.com

The opinions expressed herein or statements made in the above column are solely those of the author and do not necessarily reflect the views of The Wisconsin Technology Network, LLC. (WTN). WTN, LLC, accepts n......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 04/23/06


Related biology technology :

1. June 30 is deadline to claim up to $223.9M in Microsoft settlement
2. Wisconsin firms wont rush to adopt Microsoft Vista
3. Microsoft to distribute $224M as part of settlement
4. Berbee wins two Microsoft awards
5. How Intuit competes with Microsoft, IRS
6. Oracle out, Microsoft in for state e-mail project
7. Microsoft gives software to Milwaukee education non-profit
8. Sonic Foundry earns respect from Microsoft
9. Berbee designated a Microsoft Small Business Specialist
10. Wisconsin Supreme Court rules against Microsoft
11. Inacom named Microsofts favorite learning solutions partner of the year
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):